Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Increasing your credit card rewards earnings is easier than you think. Explore simple strategies to enhance your rewards quickly.
21,216 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Amazon trimmed 16,000 jobs in early 2026, even as CEO Jeff Bezos warned AI could create a labor shortage. The clash b...
Oracle stock down 60% from its peak doesn’t tell the whole story. This article digs into the AI cloud momentum fuelin...
Could Amazon hit a $4 trillion market value by 2027? This guide breaks down the odds, drivers, and actionable moves f...
At CES 2026, Jensen Huang highlighted memory as AI's key bottleneck. This shift sent memory stocks like Micron and Sa...
Bloom Energy has surged in 2026 on AI infrastructure bets, but a July pullback raises questions about the stock's nex...
A quiet, strategic move by Warren Buffett's Berkshire Hathaway placed a small bet on The New York Times. Here’s what ...
When a big shareholder starts selling, the market pays attention. This article explains what this major investor dump...
A prominent hedge fund reduced its Wix stake by 25,000 shares in late 2025. This article breaks down what dorsal capi...
The iShares Global Consumer Staples ETF outpaced the S&P 500 over the past year while delivering steadier risk. Walma...
If you’re planning for a decade of growth, two tech stocks stand out as durable picks. Here’s a clear, practical guid...
A high dividend yield can be tempting, but sustainability matters. This guide breaks down the pros and cons of should...